Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. A.A. (Adriaan) Voors

Publicaties

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D

Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach

Epicardial adipose tissue and pericardial constraint in heart failure with preserved ejection fraction

Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure

IL-17 is associated with disease severity and targetable inflammatory processes in heart failure

Immunomodulation and immunopharmacology in heart failure

Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results

Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial

Lees meer

Pers/media

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Novità nel trattamento dello scompenso cardiaco acuto

Health Industry News

PRNewswire Latest Health News

EMPULSE shows empagliflozin benefit in acute heart failure

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Dr Adriaan Voors: Health Care Reimbursement May Affect SGLT2 Inhibitor Uptake

Lees meer